iZafe Group AB Series B
Research iZafe Group AB Series B (IZAFE-B) on Bullrun: market cap SEK 150.44M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerIZAFE-B
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencySEK
- Market capSEK 150.44M
- Financial periodQ1 2026
- RevenueSEK 2.42M
- Net income-SEK 6.48M
- Free cash flow-SEK 4.65M
- Gross margin69.5%
Valuation Snapshot
latest market cap is SEK 150.44M.
About iZafe Group AB Series B
iZafe Group AB (publ), a medical technology company, engages in the research, development, and marketing of digital medical solutions and services for safer drug management at home. The company provides Dosell, an automated medication dispenser that handles medication pouches, smart pillboxes, facilitates and enables independent medication, and reminds and alerts in the scheduled doses. It also offers Pilloxa, a platform that provides real-time insights and improved data quality to empower and motivate patients.
Frequently asked questions
What is iZafe Group AB Series B's market cap?
iZafe Group AB Series B's market capitalization is SEK 150.44M.
What does iZafe Group AB Series B do?
iZafe Group AB (publ), a medical technology company, engages in the research, development, and marketing of digital medical solutions and services for safer drug management at home.